decreased systemic vascular resistance_Stk39<tm2.1Arte>/Stk39<tm2.1Arte>

http://metadb.riken.jp/0004879IC57BL6JStk39tm21ArteStk39tm21ArteStk39tm21Arte

decreased systemic vascular resistance_Stk39<tm2.1Arte>/Stk39<tm2.1Arte>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• serine/threonine kinase 39
  http://metadb.riken.jp/db/mgi_rdf/MGI:1858416

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Stk39<tm2.1Arte>/Stk39<tm2.1Arte>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Stk39<tm2.1Arte>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased systemic vascular resistance
  http://purl.obolibrary.org/obo/MP_0004879

文献

http://purl.org/net/cito/citesAsAuthority

• Jinwei. Zhang, et.al., Critical role of the SPAK protein kinase CCT domain in controlling blood pressure., Human molecular genetics, 2015, 24
  http://rdf.ncbi.nlm.nih.gov/pubmed/25994507